190 related articles for article (PubMed ID: 33492646)
1. Clinical practice guidelines for high-resolution breast PET, 2019 edition.
Satoh Y; Kawamoto M; Kubota K; Murakami K; Hosono M; Senda M; Sasaki M; Momose T; Ito K; Okamura T; Oda K; Kuge Y; Sakurai M; Tateishi U; Fujibayashi Y; Magata Y; Yoshida T; Waki A; Kato K; Hashimoto T; Uchiyama M; Kinuya S; Higashi T; Magata Y; Machitori A; Maruno H; Minamimoto R; Yoshinaga K
Ann Nucl Med; 2021 Mar; 35(3):406-414. PubMed ID: 33492646
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
Satoh Y; Motosugi U; Imai M; Onishi H
Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
[TBL] [Abstract][Full Text] [Related]
3. Dedicated phantom tools using traceable
Okamoto M; Hasegawa T; Oda K; Miyatake H; Kikuchi K; Inoue Y; Satoh Y; Inaoka Y; Kawamoto M; Shima K; Kanbayashi K; Yoshii M; Kanno T; Wagatsuma K; Hashimoto M
Radiol Phys Technol; 2023 Mar; 16(1):49-56. PubMed ID: 36622563
[TBL] [Abstract][Full Text] [Related]
4. A preliminary report of breast cancer screening by positron emission mammography.
Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
[TBL] [Abstract][Full Text] [Related]
5. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
[TBL] [Abstract][Full Text] [Related]
6. The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition.
Kubota K; Nakashima K; Nakashima K; Kataoka M; Inoue K; Goto M; Kanbayashi C; Hirokaga K; Yamaguchi K; Suzuki A
Breast Cancer; 2024 Mar; 31(2):157-164. PubMed ID: 37973686
[TBL] [Abstract][Full Text] [Related]
7. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition.
Uematsu T; Nakashima K; Kikuchi M; Kubota K; Suzuki A; Nakano S; Hirokaga K; Yamaguchi K; Saji S; Iwata H
Breast Cancer; 2020 Jan; 27(1):17-24. PubMed ID: 31734900
[TBL] [Abstract][Full Text] [Related]
8. [Imaging of cancer activity and range of tumor involvement--applying to breast cancer].
Shibata K; Uno K; Wu J; Ko W
Rinsho Byori; 2007 Jul; 55(7):648-55. PubMed ID: 17718061
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
Masumoto N; Kadoya T; Sasada S; Emi A; Arihiro K; Okada M
Breast Cancer Res Treat; 2018 Sep; 171(2):315-323. PubMed ID: 29779072
[TBL] [Abstract][Full Text] [Related]
10. Texture Analysis in the Diagnosis of Primary Breast Cancer: Comparison of High-Resolution Dedicated Breast Positron Emission Tomography (dbPET) and Whole-Body PET/CT.
Satoh Y; Hirata K; Tamada D; Funayama S; Onishi H
Front Med (Lausanne); 2020; 7():603303. PubMed ID: 33425949
[No Abstract] [Full Text] [Related]
11. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
Nishimatsu K; Nakamoto Y; Miyake KK; Ishimori T; Kanao S; Toi M; Togashi K
Eur J Radiol; 2017 May; 90():138-145. PubMed ID: 28583624
[TBL] [Abstract][Full Text] [Related]
12. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
Eur J Surg Oncol; 2018 Apr; 44(4):444-448. PubMed ID: 29396328
[TBL] [Abstract][Full Text] [Related]
13. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
Sasada S; Shiroma N; Goda N; Kajitani K; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
Breast Cancer Res Treat; 2019 Oct; 177(3):651-657. PubMed ID: 31267329
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size.
Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T
Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346
[TBL] [Abstract][Full Text] [Related]
15. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS
Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801
[TBL] [Abstract][Full Text] [Related]
16. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
Sakaguchi R; Kataoka M; Kanao S; Miyake KK; Nakamoto Y; Sugie T; Toi M; Mikami Y; Togashi K
Ann Nucl Med; 2019 Aug; 33(8):570-578. PubMed ID: 31115856
[TBL] [Abstract][Full Text] [Related]
17. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
Buscombe JR; Holloway B; Roche N; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
[TBL] [Abstract][Full Text] [Related]
18. Advantages and limitations of FDG PET in the follow-up of breast cancer.
Lind P; Igerc I; Beyer T; Reinprecht P; Hausegger K
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S125-34. PubMed ID: 15085295
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of an LSO PET detector for breast cancer imaging.
Doshi NK; Shao Y; Silverman RW; Cherry SR
Med Phys; 2000 Jul; 27(7):1535-43. PubMed ID: 10947256
[TBL] [Abstract][Full Text] [Related]
20. A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.
Marshall C; Mustafa S; Wheatley DC; Eremin JE; El-Sheemy M; Jibril JA; Eremin O; Griffiths PA
Nucl Med Commun; 2004 Jul; 25(7):721-5. PubMed ID: 15208500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
